(Reuters) - Achaogen Inc said on Tuesday U.S. health regulators cleared its antibiotic to treat adults with complicated urinary tract infections, but declined approval for treating bloodstream infections.
from Reuters: Health News https://ift.tt/2K909RQ
No comments:
Post a Comment